文献速递肝病消化道肿瘤与早癌

非酒精性脂肪性肝病相关肝细胞癌的流行病学与风险分层

Epidemiology and risk-stratification of NAFLD-associated HCC.
PubMed 文献 · J Hepatol · 2021-08-25

非酒精性脂肪性肝病(NAFLD)预计将成为许多国家肝细胞癌(HCC)的主要原因。肥胖、糖尿病、西班牙裔及PNPLA3等基因多态性等NAFLD风险因素也与HCC独立相关。脂肪毒性及氧化性DNA损伤可诱导肝癌发生,这或可解释NAFLD相关HCC尤其在无肝硬化时发生。识别无肝硬化但HCC风险足够高的NAFLD患者以进行筛查是重大临床挑战,目前尚无验证的多因素HCC风险计算器。

要点

  • NAFLD预计成为多国HCC主要原因
  • 肥胖、糖尿病、西班牙裔及PNPLA3等基因多态性与HCC独立相关
  • 无肝硬化NAFLD患者HCC筛查高风险人群识别困难

核心结论

  • NAFLD相关HCC的流行病学负担预计增加,但缺乏验证的风险分层工具。

研究设计与样本

  • 综述,未报告系统检索范围与样本量。

主要发现

  • NAFLD预计成为许多国家HCC的主要原因。
  • 肥胖、糖尿病、西班牙裔及PNPLA3、TM6SF2、GCKR、MBOAT7、HSD17B13基因多态性与HCC独立相关。
  • 脂肪毒性及氧化性DNA损伤可诱导肝癌发生。
  • NAFLD/NASH是无肝硬化HCC的主要原因之一。

临床怎么用

  • 目前尚无验证的NAFLD患者HCC风险计算器,临床需综合评估多种风险因素与纤维化分期。

局限性

  • 未报告系统检索策略及纳入研究的具体特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Non-alcoholic fatty liver disease (NAFLD) is projected to become the leading cause of hepatocellular carcinoma (HCC) in many countries. Many risk factors for NAFLD are also independently associated with HCC, including obesity, diabetes, Hispanic ethnicity and genetic polymorphisms in PNPLA3, TM6SF2, GCKR, MBOAT7 and HSD17B13. Steatosis-related lipotoxicity and oxidative DNA damage can induce hepatocarcinogenesis. These factors may explain the association between NAFLD and HCC, especially in the absence of cirrhosis. In fact, NAFLD/NASH is a leading cause of HCC in the absence of cirrhosis. Identifying patients with pre-cirrhotic NAFLD who have a high enough HCC risk to justify HCC screening represents one of the greatest clinical challenges in NAFLD. Validated models that combine multiple risk factors and fibrosis stage into "HCC risk calculators" are not yet available for patients with NAFLD. Development of such tools would enable risk stratification, identification of high-risk patients even in the absence of cirrhosis, and individualised (risk-based) surveillance strategies.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Ioannou GN. Epidemiology and risk-stratification of NAFLD-associated HCC. J Hepatol. 2021. PMID: 34453963. doi:10.1016/j.jhep.2021.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。